Concepedia

Mei Ding

MD

14

Publications

760

Citations

13

H-Index

2008

Active since

Affiliations

Novartis (Singapore)(Current)

National University of Singapore

Novartis (United States)

Novartis (Switzerland)

Novartis Institutes for BioMedical Research

Mei Ding is an author at Novartis (Singapore) specializing in medicine, pharmacology, and natural sciences.

ORCID

Top concepts

Publications per year

2008–2023

14

Publications

14

Small Molecule Inhibitors That Selectively Block Dengue Virus Methyltransferase

Siew Pheng Lim, Louis Sebastian Sonntag, Christian G. Noble et al. · Journal of Biological Chemistry · 2010 · 185 citations · Full text

Discovery of Dengue Virus NS4B Inhibitors

Qing-Yin Wang, Hongping Dong, Bin Zou et al. · Journal of Virology · 2015 · 100 citations · Full text

, , +14

NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models

Stephanie Moquin, Oliver Simon, Ratna Karuna et al. · Science Translational Medicine · 2021 · 81 citations

, , +16

Lead Optimization of Spiropyrazolopyridones: A New and Potent Class of Dengue Virus Inhibitors

Bin Zou, Wai Ling Chan, Mei Ding et al. · ACS Medicinal Chemistry Letters · 2015 · 70 citations · Full text

, , +19

Spns1 is a lysophospholipid transporter mediating lysosomal phospholipid salvage

Menglan He, Alvin C. Y. Kuk, Mei Ding et al. · Proceedings of the National Academy of Sciences · 2022 · 61 citations · Full text

, , +18

Rows per page

1–5 of 14